Skip to main content
Clinical Trials/CTRI/2023/01/049126
CTRI/2023/01/049126
Not yet recruiting
未知

Treatment of dry eczema by using liquid mixture containing extract obtained from manjishtha and pharmaceutical excipients.

Mrs Hema Vishal Nalamwar0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: L20-L30- Dermatitis and eczema
Sponsor
Mrs Hema Vishal Nalamwar
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Mrs Hema Vishal Nalamwar

Eligibility Criteria

Inclusion Criteria

  • 1\) Adult male or female patient diagnosed with dry eczema. ( 30 to 60 yrs)
  • 2\) Adult male or female patient diagnosed with dry eczema and not treated with any oral or external medicine in past 15 days before recruitment (if the patient is on any other oral or external medicine it shall be stopped for 15 days then the treatment which is subject matter of this study shall begin).
  • 3\) Individuals willing to sign informed consent.

Exclusion Criteria

  • 1\) Individuals allergic to manjishtha or allergic to any pharmaceutical excipient.
  • 2\) Individuals suffering from serious neurological defects, skin cancer, immunodeficiency, bullous skin disease, aplasia, albinism, weeping lesions and very severe cases (it means extensively spread lesions and not refers to signs of individual lesion).
  • 3\) Individuals not willing to sign informed consent.
  • 4\) Individuals currently participating in any other clinical study.

Outcomes

Primary Outcomes

Not specified

Similar Trials